Nutrition support during cancer chemotherapy and radiotherapy;Nutrition au cours des radiothérapies et chimiothérapies

Nutrition Clinique et Metabolisme

Volumn 15, Issue 4, 2001, Pages 308-317

  Bachmann, P ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

Cancer; Enteral nutrition; Parenteral nutrition

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; ARTIFICIAL FEEDING; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DIET THERAPY; DIETARY INTAKE; DISEASE COURSE; ENTERIC FEEDING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MALNUTRITION; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; TREATMENT INDICATION;

EID: 17544390288     PISSN: 09850562     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0985-0562(01)00078-4     Document Type: Article

References (82)

1. Prognostic effect of weight loss prior to chemotherapy in cancer patients
2. Impact of patient weight on non-relapse mortality after marrow transplantation
3. Prognostic factors for survival in patients with inoperable lung cancer
4. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?
5. Definition of standardized nutritional assessment and interventional pathways in oncology
6. Impact of nutritional status on DRG length of stay
7. Clinical significance of weight loss in cancer patients: Rationale for the use of anabolic agents in the treatment of cancer-related cachexia
8. Symptoms potentially influencing weight loss in a cancer population
9. Clinical parameters related to anorexia
10. Prevalence of malnutrition in patients in general Practice
11. Food avoidance in patients undergoing cancer chemotherapy
12. Learned food aversions and cancer anorexia
13. Standards, options et recommandations pour l'utilisation des antiémétiques en cancérologie
14. Une nouvelle stratégie hospitalière: Le CLAN (Comité de Liaison-Alimentation Nutrition)
15. Shortened length of stay is an outcome benefit of early nutritional intervention
16. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer
17. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: A prospective, randomized study
18. A critical, systematic analysis of the use of oral nutritional supplements in the community
19. Nutrition management of patients with neoplastic disease of the head and neck treated with radiation therapy
20. Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre
21. Etat nutritionnel et qualité de vie pendant la radiothérapie externe des tumeurs des voies aéro-digestives supérieures [Résumé]
22. Nutritional consequences of the radiotherapy of head and neck cancer
23. Nutritional support as an adjunct to radiation therapy
24. The effect of oral nutritional supplements on head and neck cancer
25. Impact of nutritional supplementation on the treatment delay and morbidity in patients with head and neck tumors treated with irradiation
26. Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy
27. Nutritional evaluation and dietetic care in cancer patients treated with radiotherapy: Prospective study
28. Radiothérapie pour cancer ORL: Intérêt du support nutritionnel précoce [Résumé]
29. The influence of supportive nutritional therapy via percutaneous endoscopically guided gastrostomy on the quality of life of cancer patients
30. Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: A two year study
31. Percutaneous endoscopic gastrostomy: Cost/benefit analysis in patients with carcinoma of the upper aero-digestive tract
32. Nutritional rehabilitation in patients with advanced head and neck cancer with radiation therapy
33. Nutritional support in adult cancer patient
34. Reduction of methotrexate toxicity with improved nutritional status in tumor-bearing animals
35. Effects of protein-calorie malnutrition and refeeding on fluorouracil toxicity
36. Effect of a low-protein diet on doxorubicin pharmacokinetics in the rabbit
37. Effect of protein-calorie malnutrition on methotrexate pharmacokinetics
38. Effect of nutritional status on the hepatobiliary excretion of Methotrexate in the rat
39. Pharmacokinetics of methotrexate in adult Indian patients and its relationship to nutritional status
40. Predicting etoposide toxicity: Relationship to organ function and protein binding
41. No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion
42. Impact of nutrition on pharmacokinetics of anti-neoplastic agents
43. Total parenteral nutrition and cancer clinical trials
44. Parenteral nutrition in cancer patients undergoing chemotherapy: A meta-analysis
45. Nutrition support in patients with cancer: What do the data really show?
46. Oncologic parenteral nutrition: A meta-analysis
47. The effect of intravenous hyperalimentation on the dietary intake of patients with small cell lung cancer. A randomized trial
48. Total parenteral nutrition as an adjuvant to patients undergoing chemotherapy for testicular carcinoma: Protection of body composition - A randomized, prospective study
49. Adverse effects of treatment gaps in outcome of radiotherapy for laryngeal cancer
50. Similar decrease in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers
51. Total parenteral nutrition with complete nutritive mixtures: An artificial gut in cancer patients
52. Elemental diet as an adjuvant for patients with locally advanced gastrointestinal cancer receiving radiation therapy: A prospectively randomized study
53. Nutritional support in patients with cancer of the esophagus: Impact on nutritional status, patient compliance to therapy, and survival
54. Role of nutrition support during induction chemotherapy in esophageal cancer
55. Linee guida per l'impiego della nutrizione parenterale ed enterale S Neoplasie
56. Stimulation of tumor growth by nutrition support
57. Modulation of cell cycle kinetics in human cancer with total parenteral nutrition
58. Nutritional support in the cancer-bearing host. Effects on host and tumor
59. Tumor and host tissue responses to branched-chain amino acid supplementation of patients with cancer
60. Total parenteral nutrition and tumor growth in malnourished patients with gastric cancer
61. Pre-operative nutritional support and tumor cell kinetics in malnourished patients with gastric cancer
62. Effects of parenteral nutrition support and chemotherapy on the phasic composition of tumor cells in gastrointestinal cancer
63. Tumor cytokinetic response to total parenteral nutrition in patients with head and neck cancers
64. Nutritional support of the cancer patient: Issues and dilemmas
65. The impact of malnutrition on treatment results in breast cancer
66. Effect of nutritional status on responses to therapy
67. Parenteral nutrition in patients receiving cancer chemotherapy
68. Nutrition support in clinical practice: Review of published data and recommendations for future research directions
69. Nutritional and metabolic assessment of the hospitalized patient
70. Nutrition arfificielle périopératoire en chirurgie programmée de l'adulte: Recommandations du jury de la conférence de consensus
71. Parenteral versus enteral nutrition in cancer patients: Indications and practice
72. Energy expenditure in malnourished cancer patients
73. Energy expenditure in malnourished gastrointestinal cancer patients
74. Macronutrient requirements in malnourished cancer patient: How much of what and why?
75. Energy expenditure and protein metabolism in human immunodeficiency virus infection and cancer cachexia
76. Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer
77. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients
78. Energy balance in non small cell lung carcinoma patients before and after surgical resection of their tumors
79. Evidence for tumor- induced changes in basal metabolic rate in patients with small cell lung cancer
80. Elevated energy expenditure in cancer patients with solid tumors
81. Good clinical practice in nutritional management of head and neck cancer patients
82. Micronutrient requirements of cancer patients